İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2016 · article

Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study

YÖKSİS OpenAlex Açık erişim · gold Üst %10
Yıl2016
Atıf73OpenAlex
Yüzdelik%96,3
FWCI5,621,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıAnnals of Clinical Microbiology and Antimicrobials
  • Katalog eşleşmesi (ISSN)Annals of Clinical Microbiology and Antimicrobials
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex İngilizce

BACKGROUND: Staphylococcus aureus is one of the causes of both community and healthcare-associated bacteremia. The attributable mortality of S. aureus bacteremia (SAB) is still higher and predictors for mortality and clinical outcomes of this condition are need to be clarified. In this prospective observational study, we aimed to examine the predictive factors for mortality in patients with SAB in eight Turkish tertiary care hospitals. METHODS: Adult patients with signs and symptoms of bacteremia with positive blood cultures for S. aureus were included. All data for episodes of SAB including demographics, clinical and laboratory findings, antibiotics, and outcome were recorded for a 3-year (2010-2012) period. Cox proportional hazard model with forward selection was used to assess the independent effect of risk factors on mortality. A 28-day mortality was the dependent variable in the Cox regression analysis. RESULTS: A total of 255 episodes of SAB were enrolled. The median age of the patients was 59 years. Fifty-five percent of the episodes were considered as primary SAB and vascular catheter was the source of 42.1 %. Healthcare associated SAB was defined in 55.7 %. Blood cultures yielded methicillin-resistant S. aureus (MRSA) as a cause of SAB in 39.2 %. Initial empirical therapy was inappropriate in 28.2 %. Although overall mortality was observed in 52 (20.4 %), 28-day mortality rate was 15.3 %. Both the numbers of initial inappropriate empirical antibiotic treatment and the median hours to start an appropriate antibiotic between the cases of fatal outcome and survivors after fever onset were found to be similar (12/39 vs 60/216 and 6 vs 12 h, respectively; p > 0.05). High Charlson comorbidity index (CCI) score (p = 0.002), MRSA (p = 0.017), intensive care unit (ICU) admission (p < 0.001) and prior exposure to antibiotics (p = 0.002) all were significantly associated with mortality. The Cox analysis defined age [Hazard Ratio (HR) 1.03; p = 0.023], ICU admission (HR 6.9; p = 0.002), and high CCI score (HR 1.32; p = 0.002) as the independent predictive factors mortality. CONCLUSIONS: The results of this prospective study showed that age, ICU stay and high CCI score of a patient were the independent predictors of mortality and MRSA was also significantly associated with mortality in SAB.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

73atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 9 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2021 Antibacterial hybrid coatings from halloysite-immobilized lysostaphin and waterborne polyurethanesAtıf 18 · OpenAlex
  2. 2021 Antibacterial hybrid coatings from halloysite-immobilized lysostaphin and waterborne polyurethanesAtıf 18 · OpenAlex
  3. 2021 Antibacterial hybrid coatings from halloysite-immobilized lysostaphin and waterborne polyurethanesAtıf 18 · OpenAlex
  4. 2023 Prevalence and resistance trends of Gram positive cocci Staphylococcus aereus and Enterococcus spp. in a tertiary care hospitalAtıf 4 · OpenAlex
  5. 2019 STAPHYLOCOCCUS AUREUS BAKTERİYEMİLERİNDE MORTALİTE RİSK FAKTÖRLERİNİN ANALİZİ: SEFAZOLİN DAHA İYİ SONUÇLA İLİŞKİLİAtıf 3 · OpenAlex
  6. 2019 STAPHYLOCOCCUS AUREUS BAKTERİYEMİLERİNDE MORTALİTE RİSK FAKTÖRLERİNİN ANALİZİ: SEFAZOLİN DAHA İYİ SONUÇLA İLİŞKİLİAtıf 3 · OpenAlex
  7. 2019 STAPHYLOCOCCUS AUREUS BAKTERİYEMİLERİNDE MORTALİTE RİSK FAKTÖRLERİNİN ANALİZİ: SEFAZOLİN DAHA İYİ SONUÇLA İLİŞKİLİAtıf 3 · OpenAlex
  8. 2025 Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemiaAtıf 1 · OpenAlex
  9. 2025 Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemiaAtıf 1 · OpenAlex

Yazarlar

21
  1. Mesut Yilmaz 1
  2. NAZİF ELALDI SİVAS CUMHURİYET ÜNİVERSİTESİ 2
  3. İLKER İNANÇ BALKAN İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 3
  4. FERHAT ARSLAN 4
  5. Ayşe Alga Batırel 5
  6. MUSTAFA ZAHİR BAKICI 6
  7. Mustafa Gökhan Gözel 7
  8. Sevil Alkan 8
  9. Aygül Doğan Çelik 9
  10. MELTEM ARZU YETKİN 10
  11. HURREM BODUR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ 11
  12. AYŞE MELDA PAYASLIOĞLU 12
  13. Fatma Aybala Altay 13
  14. İRFAN ŞENCAN SAĞLIK BİLİMLERİ ÜNİVERSİTESİ 14
  15. EMEL AZAK KARALİ 15
  16. SİBEL GÜNDEŞ 16
  17. BAHADIR CEYLAN 17
  18. RECEP ÖZTÜRK 18
  19. Hakan Leblebicioglu 19
  20. Haluk Vahaboglu 20
  21. ALİ MERT 21